We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

38 hedge funds and large institutions have $39.5M invested in InVivo Therapeutics Holdings Corp in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

65% more call options, than puts

Call options by funds: $3.91M | Put options by funds: $2.36M

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 37 → 38 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less capital invested

Capital invested by funds: $43.9M → $39.5M (-$4.44M)

Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
10
Reduced
3
Closed
5
Calls
$3.91M
Puts
$2.36M
Net Calls
+$1.55M
Net Calls Change
-$2.31M

Top Buyers

Rank Fund Capital Flow
1
WF
Welch & Forbes
Massachusetts
+$1.04M
2
BIT
BlackRock Institutional Trust
California
+$743K
3
Goldman Sachs
Goldman Sachs
New York
+$446K
4
Group One Trading
Group One Trading
Illinois
+$446K
5
EIM
Emerson Investment Management
Massachusetts
+$297K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$594K
2
Citigroup
Citigroup
New York
-$297K
3
TCIM
TIAA CREF Investment Management
New York
-$297K
4
Millennium Management
Millennium Management
New York
-$173K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$149K
Name Holding Trade Value Shares
Change 		Change in
Stake
WF
1
Welch & Forbes
Massachusetts
$6.5M +$1.04M +7 +17%
Vanguard Group
2
Vanguard Group
Pennsylvania
$6.49M +$149K +1 +2%
BFA
3
BlackRock Fund Advisors
California
$5.16M +$149K +1 +3%
BIT
4
BlackRock Institutional Trust
California
$4.77M +$743K +5 +17%
State Street
5
State Street
Massachusetts
$2.46M – – –
Northern Trust
6
Northern Trust
Illinois
$2M +$149K +1 +7%
ICM
7
IMS Capital Management
Oregon
$1.78M +$149K +1 +8%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.2M – – –
Wellington Management Group
9
Wellington Management Group
Massachusetts
$737K – – –
Morgan Stanley
10
Morgan Stanley
New York
$708K +$149K +1 +25%
Goldman Sachs
11
Goldman Sachs
New York
$684K +$446K +3 +150%
BIM
12
BlackRock Investment Management
Delaware
$682K – – –
TCIM
13
TIAA CREF Investment Management
New York
$627K -$297K -2 -29%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$593K -$149K -1 -20%
EIM
15
Emerson Investment Management
Massachusetts
$534K +$297K +2 +100%
Group One Trading
16
Group One Trading
Illinois
$445K +$446K +3 New
LPL Financial
17
LPL Financial
California
$381K +$297K +2 +200%
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$354K – – –
UBS Group
19
UBS Group
Switzerland
$281K – – –
TA
20
Teachers Advisors
New York
$277K – – –
Charles Schwab
21
Charles Schwab
California
$270K – – –
Stifel Financial
22
Stifel Financial
Missouri
$268K – – –
LCM
23
Landscape Capital Management
New Jersey
$213K +$297K +2 New
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$182K – – –
AIM
25
Alambic Investment Management
California
$181K +$149K +1 New
1
2 3

NVIV Hedge Fund Activity: Q4 2015 in Review

38 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q4 2015, worth a combined $39.5M — down 10% from $43.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVIV positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Welch & Forbes, adding an estimated $1.04M. The largest seller was Susquehanna International Group, cutting an estimated $594K.

  • 38 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q4 2015, up from 37 in Q3 2015.
  • Funds reported $39.5M of InVivo Therapeutics Holdings Corp stock for Q4 2015, down 10% quarter-over-quarter.
  • 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q4 2015 and 5 closed out, a net change of +1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q4 2015 was Welch & Forbes, an estimated $1.04M added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q4 2015 was Susquehanna International Group, an estimated $594K sold.

Based on aggregated 13F filings for Q4 2015.